UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer

The New England journal of medicine, 2020-02, Vol.382 (6), p.514-524

2020

Volltextzugriff (PDF)

Pembrolizumab in the Treatment of Breast Cancer

The New England journal of medicine, 2022-07, Vol.387 (3), p.273-274

Pivot, Xavier

2022

Volltextzugriff (PDF)

Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

The lancet oncology, 2013-09, Vol.14 (10), p.962-970

2013

Volltextzugriff (PDF)

Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine

Breast cancer (Tokyo, Japan), 2018-05, Vol.25 (3), p.370-374

2018

Volltextzugriff (PDF)

A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients

Annals of oncology, 2008-09, Vol.19 (9), p.1547-1552

2008

Volltextzugriff (PDF)

Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients

Journal of cachexia, sarcopenia and muscle, 2022-06, Vol.13 (3), p.1896-1907

2022

Volltextzugriff (PDF)

A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study

BMC cancer, 2017-06, Vol.17 (1), p.425-425, Article 425

2017

Volltextzugriff (PDF)

Prospective Clinical Utility Study of the Use of the 21‐Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor‐Positive Early Invasive Breast Cancer: Results From the SWITCH Study

The oncologist (Dayton, Ohio), 2015-08, Vol.20 (8), p.873-879

2015

Volltextzugriff (PDF)

Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting

BMC cancer, 2023-01, Vol.23 (1), p.112-112, Article 112

2023

Volltextzugriff (PDF)

Classic cytotoxic drugs: a narrow path for regulatory approval

The lancet oncology, 2017-03, Vol.18 (3), p.279-281

Pivot, Xavier

2017

Volltextzugriff (PDF)

A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients

Journal of cachexia, sarcopenia and muscle, 2024-02, Vol.15 (1), p.292-305

2024

Volltextzugriff (PDF)

Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review

Cancer medicine (Malden, MA), 2014-12, Vol.3 (6), p.1502-1511

2014

Volltextzugriff (PDF)

Adjuvant chemotherapy for local relapse breast cancer

The lancet oncology, 2014-02, Vol.15 (2), p.125-126

Pivot, Xavier

2014

Volltextzugriff (PDF)

Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial

BMC cancer, 2012-12, Vol.12 (1), p.603-603, Article 603

2012

Volltextzugriff (PDF)

Cisplatin in Combination With Either Gemcitabine or Irinotecan in Carcinomas of Unknown Primary Site: Results of a Randomized Phase II Study—Trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01)

Journal of clinical oncology, 2003-09, Vol.21 (18), p.3479-3482

2003

Volltextzugriff (PDF)

Age, Neurological Status MRC Scale, and Postoperative Morbidity are Prognostic Factors in Patients with Glioblastoma Treated by Chemoradiotherapy

Clinical Medicine Insights. Oncology, 2016-01, Vol.2016 (10), p.77-82

2016

Volltextzugriff (PDF)

Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer

World journal of surgical oncology, 2009-02, Vol.7 (1), p.14-14, Article 14

2009

Volltextzugriff (PDF)

A new era for treatment development in HER2-positive breast cancer

The lancet oncology, 2018-02, Vol.19 (2), p.160-162

2018

Volltextzugriff (PDF)

Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer

Clinical Medicine Insights. Oncology, 2013-01, Vol.2013 (7), p.1-12

2013

Volltextzugriff (PDF)

Persistent taxane‐induced neuropathy in elderly patients treated for localized breast cancer

The breast journal, 2020-12, Vol.26 (12), p.2376-2382

2020

Volltextzugriff (PDF)

The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBC

Clinical breast cancer, 2022-04, Vol.22 (3), p.223-234

2022

Volltextzugriff (PDF)

Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy

European journal of applied physiology, 2023-07, Vol.123 (7), p.1567-1581

2023

Volltextzugriff (PDF)

Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer

Cancer, 2023-01, Vol.129 (2), p.215-225

2023

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

ThemaChemotherapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(55)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(50)
Science & Technology
(50)
Oncology
(42)
Humans
(40)
Female
(38)
Breast Cancer
(32)
Middle Aged
(27)
Aged
(25)
Breast Neoplasms - Drug Therapy
(24)
Adult
(23)
Cancer Therapies
(22)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Life Sciences
(17)
Cancer
(15)
Tumors
(14)
Antineoplastic Agents
(13)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Metastasis
(12)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial

Pembrolizumab in the Treatment of Breast Cancer

Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine

A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients

Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients

A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study

Prospective Clinical Utility Study of the Use of the 21‐Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor‐Positive Early Invasive Breast Cancer: Results From the SWITCH Study

Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting

Classic cytotoxic drugs: a narrow path for regulatory approval

A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients

Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review

Adjuvant chemotherapy for local relapse breast cancer

Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial

Cisplatin in Combination With Either Gemcitabine or Irinotecan in Carcinomas of Unknown Primary Site: Results of a Randomized Phase II Study—Trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01)

Age, Neurological Status MRC Scale, and Postoperative Morbidity are Prognostic Factors in Patients with Glioblastoma Treated by Chemoradiotherapy

Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer

A new era for treatment development in HER2-positive breast cancer

Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer

Persistent taxane‐induced neuropathy in elderly patients treated for localized breast cancer

The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBC

Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy

Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer

Aktive Filter

Suchergebnisse filtern